Funda Orhan
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.
Journal: The American journal of psychiatry
Published: April 01, 2025
Cardiovascular protein profiling in patients with first-episode psychosis.
Journal: Schizophrenia (Heidelberg, Germany)
Published: January 14, 2025
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.
Journal: Brain, behavior, and immunity
Published: July 02, 2024
Lower complement C1q levels in first-episode psychosis and in schizophrenia.
Journal: Brain, behavior, and immunity
Published: September 27, 2023
Kynurenine Metabolites in CSF and Plasma in Healthy Males.
Journal: International journal of tryptophan research : IJTR
Published: September 12, 2023
Preanalytic handling of clinical blood samples in assessing immunological proteins - Role of storage duration.
Journal: Brain, behavior, and immunity
Published: August 07, 2023
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity.
Journal: Brain, behavior, and immunity
Published: September 26, 2022
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients.
Journal: Translational psychiatry
Published: April 26, 2022
SARS-CoV-2 promotes microglial synapse elimination in human brain organoids.
Journal: Molecular psychiatry
Published: March 04, 2022
Correction: GRK3 deficiency elicits brain immune activation and psychosis.
Journal: Molecular psychiatry
Published: November 08, 2021
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.
Journal: Nature communications
Published: September 02, 2021
Last Updated: 09/26/2026